The acquisiton by Summit-headquartered Celgene, an integrated, global pharmaceutical company, extends the company’s existing Hilltop City presence beyond its 86 Morris Ave. global headquarters location.
Combined with the completion of construction of a new 550,000-squar- foot office building at its 86 Morris Ave. location, the purchase allows Celgene to concentrate its New Jersey operations at two campuses in close proximity in Summit.
Merck announced it was leaving Summit in October, 2013 to consolidate its operations in Kenilworth.
“We are extremely pleased that Celgene will continue to develop and grow its highly successful business in its new, world-class Summit location,” said Summit Mayor Ellen Dickson. “Celgene is a long-standing community partner, and we anticipate them making the most of another exceptional property,”
Dickson added, “The announcement by Celgene, in early July, of its intention to acquire the property was a clear indication that the company values Summit as a great place to do business. Partnering with Celgene to bring about this important investment in the Summit community has been a priority for the City, and we look forward to working together with this outstanding organization for many years to come.”